본문 바로가기
KERD
논문KCI 등재

Lactobacillus-derived extracellular vesicles counteract Aβ42-induced abnormal transcriptional changes through the upregulation of MeCP2 and Sirt1 and improve Aβ pathology in Tg-APP/PS1 mice

1

조회

0

다운로드

1

인용

0

참고문헌

주제분류생화학

초록

Mounting evidence suggests that probiotics are beneficial for treating Alzheimer’s disease (AD). However, the mechanisms by which specific probiotics modify AD pathophysiology are not clearly understood. In this study, we investigated whether Lactobacillus paracasei-derived extracellular vesicles (Lpc-EV) can directly act on neuronal cells to modify amyloid-beta (Aβ)-induced transcriptional changes and Aβ pathology in the brains of Tg-APP/PS1 mice. Lpc-EV treatment in HT22 neuronal cells counteracts Aβ-induced downregulation of Brain-derived neurotrophic factor (Bdnf), Neurotrophin 3 (Nt3), Nt4/5, and TrkB receptor, and reverses Aβ-induced altered expression of diverse nuclear factors, including the downregulation of Methyl-CpG binding protein 2 (Mecp2) and Sirtuin 1 (Sirt1). Systematic siRNA-mediated knockdown experiments indicate that the upregulation of Bdnf, Nt3, Nt4/5, and TrkB by Lpc-EV is mediated via multiple epigenetic factors whose activation converges on Mecp2 and Sirt1. In addition, Lpc-EV reverses Aβ-induced downregulation of the Aβ-degrading proteases Matrix metalloproteinase 2 (Mmp-2), Mmp-9, and Neprilysin (Nep), whose upregulation is also controlled by MeCP2 and Sirt1. Lpc-EV treatment restores the downregulated expression of Bdnf, Nt4/5, TrkB, Mmp-2, Mmp-9, and Nep; induces the upregulation of MeCP2 and Sirt1 in the hippocampus; alleviates Aβ accumulation and neuroinflammatory responses in the brain; and mitigates cognitive decline in Tg-APP/PS1 mice. These results suggest that Lpc-EV cargo contains a neuroactive component that upregulates the expression of neurotrophic factors and Aβ-degrading proteases (Mmp-2, Mmp-9, and Nep) through the upregulation of MeCP2 and Sirt1, and ameliorates Aβ pathology and cognitive deficits in Tg-APP/PS1 mice.

Abstract

Mounting evidence suggests that probiotics are beneficial for treating Alzheimer’s disease (AD). However, the mechanisms by which specific probiotics modify AD pathophysiology are not clearly understood. In this study, we investigated whether Lactobacillus paracasei-derived extracellular vesicles (Lpc-EV) can directly act on neuronal cells to modify amyloid-beta (Aβ)-induced transcriptional changes and Aβ pathology in the brains of Tg-APP/PS1 mice. Lpc-EV treatment in HT22 neuronal cells counteracts Aβ-induced downregulation of Brain-derived neurotrophic factor (Bdnf), Neurotrophin 3 (Nt3), Nt4/5, and TrkB receptor, and reverses Aβ-induced altered expression of diverse nuclear factors, including the downregulation of Methyl-CpG binding protein 2 (Mecp2) and Sirtuin 1 (Sirt1). Systematic siRNA-mediated knockdown experiments indicate that the upregulation of Bdnf, Nt3, Nt4/5, and TrkB by Lpc-EV is mediated via multiple epigenetic factors whose activation converges on Mecp2 and Sirt1. In addition, Lpc-EV reverses Aβ-induced downregulation of the Aβ-degrading proteases Matrix metalloproteinase 2 (Mmp-2), Mmp-9, and Neprilysin (Nep), whose upregulation is also controlled by MeCP2 and Sirt1. Lpc-EV treatment restores the downregulated expression of Bdnf, Nt4/5, TrkB, Mmp-2, Mmp-9, and Nep; induces the upregulation of MeCP2 and Sirt1 in the hippocampus; alleviates Aβ accumulation and neuroinflammatory responses in the brain; and mitigates cognitive decline in Tg-APP/PS1 mice. These results suggest that Lpc-EV cargo contains a neuroactive component that upregulates the expression of neurotrophic factors and Aβ-degrading proteases (Mmp-2, Mmp-9, and Nep) through the upregulation of MeCP2 and Sirt1, and ameliorates Aβ pathology and cognitive deficits in Tg-APP/PS1 mice.

참고문헌 (60)

  1. Long, J. M., "Alzheimer disease: an update on pathobiology and treatment strategies", Cell, 179, pp.312~339 (2019)
  2. Scheltens, P., "Alzheimer’s disease", Lancet, 397, pp.1577~1590 (2021)
  3. Alvira-Botero, X., "Clearance of amyloid-β peptide across the choroid plexus in Alzheimer’s disease", Curr. Aging Sci, 3, pp.219~229 (2010)
  4. Tarasoff-Conway, J. M., "Clearance systems in the brain—implications for Alzheimer disease", Nat. Rev. Neurol, 11, pp.457~470 (2015)
  5. Birch, A. M., "Modulation of inflammation in transgenic models of Alzheimer’s disease", J. Neuroinflammation, 11, pp.25~ (2014)
  6. Kinney, J. W., "Inflammation as a central mechanism in Alzheimer’s disease", Alzheimers Dement, 4, pp.575~590 (2018)
  7. Myers, A., "Overview of transgenic mouse models for Alzheimer’s disease", Curr. Protoc. Neurosci, 89, pp.e81~ (2019)
  8. Karol Kowalski, "Brain-Gut-Microbiota Axis in Alzheimer’s Disease", Journal of Neurogastroenterology and Motility (JNM), 25(1), pp.48~60 (2019), 대한소화기 기능성질환∙운동학회[DOI]
  9. Nagu, P., "Gut microbiota composition and epigenetic molecular changes connected to the pathogenesis of Alzheimer’s disease", J. Mol. Neurosci, 71, pp.1436~1455 (2021)
  10. Juli Choi, "Extracellular Vesicles Derived from Lactobacillus plantarum Increase BDNF Expression in Cultured Hippocampal Neurons and Produce Antidepressant-like Effects in Mice", Experimental Neurobiology, 28(2), pp.158~171 (2019), 한국뇌신경과학회
  11. Choi, J., "Extracellular vesicles from Gram-positive and Gram-negative probiotics remediate stress-induced depressive behavior in mice", Mol. Neurobiol, 59, pp.2715~2728 (2022)
  12. Ji Hyun Choi, "Lactobacillus paracasei-derived extracellular vesicles attenuate the intestinal inflammatory response by augmenting the endoplasmic reticulum stress pathway", Experimental and Molecular Medicine, 52, pp.1~15 (2020), 생화학분자생물학회[DOI]
  13. Bannister, A. J., "Regulation of chromatin by histone modifications", Cell Res, 21, pp.381~395 (2011)
  14. Campbell, R. R., "How the epigenome integrates information and reshapes the synapse", Nat. Rev. Neurosci, 20, pp.133~147 (2019)
  15. Fuks, F., "The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation", J. Biol. Chem, 278, pp.4035~4040 (2003)
  16. Lee, W., "MeCP2 regulates gene expression through recognition of H3K27me3", Nat. Commun, 11, pp.3140~ (2020)
  17. Karpova, N. N., "Epigenetic basis of neuronal and synaptic plasticity", Curr. Top. Med. Chem, 17, pp.771~793 (2014)
  18. Duclot, F., "Epigenetic mechanisms underlying the role of brainderived neurotrophic factor in depression and response to antidepressants", J. Exp. Biol, 218, pp.21~31 (2015)
  19. Liu, X., "The epigenetics of Alzheimer’s disease : factors and therapeutic implications", Front. Genet, 9, pp.579~ (2018)
  20. Abuhatzira, L., "MeCP2 deficiency in the brain decreases BDNF levels by REST", CoREST-mediated repression and increases TRKB production, 2007, pp.2, 214~222
  21. Kline, D. D., "Exogenous brain-derived neurotrophic factor rescues synaptic dysfunction in Mecp2-null mice", J. Neurosci, 30, pp.5303~5310 (2010)
  22. Choi, J., "Hyperoxygenation revitalizes Alzheimer’s disease pathology through the upregulation of neurotrophic factors", Aging Cell, 18, pp.e12888~ (2019)
  23. Klein, M. E., "Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA", Nat. Neurosci, 10, pp.1513~1514 (2007)
  24. Larimore, J. L., "Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-Associated MECP2 mutations", Neurobiol. Dis, 34, pp.199~211 (2009)
  25. Sartor, G. C., "Enhancement of BDNF expression and memory by HDAC inhibition requires BET bromodomain reader proteins", J. Neurosci, 39, pp.612~626 (2019)
  26. Lee, J. E., "Aging-dependent downregulation of SUV39H1histone methyltransferase increases susceptibility to stress-induced depressive behavior", Mol. Neurobiol, 58, pp.6427~6442 (2021)
  27. Hock, C., "Region-specific neurotrophin imbalances in Alzheimer disease decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas", Arch. Neurol, 57, pp.846~851 (2000)
  28. Du, Y., "Postmortem brain, cerebrospinal fluid, and blood neurotrophic factor levels in Alzheimer’s disease : a systematic review and meta-analysis", J. Mol. Neurosci, 65, pp.289~300 (2018)
  29. Chao, M. V., "Neurotrophines and their receptors", Nat. Rev. Neurosci, 4, pp.299~309 (2003)
  30. Devi, L., "7, 8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer’s disease", Neuropsychopharmacology, 37, pp.434~444 (2012)
  31. Zhang, Z., "7, 8-dihydroxyflavone prevents synaptic loss and memory deficits in a mouse model of Alzheimer’s disease", Neuropsychopharmacology, 39, pp.638~650 (2014)
  32. Jankowsky, J. L., "Co-expression of multiple transgenes in mouse CNS : a comparison of strategies", Biomol. Eng, 17, pp.157~165 (2001)
  33. Lee, J. E., "Aging increases vulnerability to stress-induced depression via upregulation of NADPH oxidase in mice", Commun. Biol, 3, pp.292~ (2020)
  34. Kim, T. K., "G9a-mediated regulation of OXT and AVP expression in the basolateral amygdala mediates stress-induced lasting behavioral depression and its reversal by exercise", Mol. Neurobiol, 53, pp.2843~2856 (2016)
  35. Lee, E. H., "Repeated exposure with short-term behavioral stress resolves pre-existing stress-induced depressive-like behavior in mice", Nat. Commun, 12, pp.6682~ (2021)
  36. Park, J. Y., "Behavioral engagement with playable objects resolves stressinduced adaptive changes by reshaping the reward system", Biol. Psychiatry, 91, pp.676~689 (2022)
  37. Plaisier, S. B., "Rank-rank hypergeometric overlap : identification of statistically significant overlap between geneexpression signatures", Nucleic Acids Res, 38, pp.e169~ (2010)
  38. Amidfar, M., "The role of CREB and BDNF in neurobiology and treatment of Alzheimer’s disease", Life Sci, 257, pp.118020~ (2020)
  39. Goldberg, E. M., "Mechanisms of epileptogenesis : a convergence on neural circuit dysfunction", Nat. Rev. Neurosci, 14, pp.337~349 (2014)
  40. Fontanet, P. A., "Pea3 transcription factors, Etv4 and Etv5, are required for proper hippocampal dendrite development and plasticity", Cereb. Cortex, 28, pp.236~249 (2018)
  41. Im, H. I., "MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212", Nat. Neurosci, 13, pp.120~1127 (2010)
  42. Mitchelmore, C., "Brain derived neurotrophic factor : epigenetic regulation in psychiatric disorders", Brain Res, 1586, pp.162~172 (2014)
  43. Gill, S., "Extracellular membrane vesicles in the three domains of life and beyond", FEMS Microbiol. Rev, 43, pp.273~303 (2019)
  44. Filip, R., "An update on the role of extracellular vesicles in the pathogenesis of necrotizing enterocolitis and inflammatory bowel diseases", Cells, 10, pp.3202~ (2021)
  45. Ñahui Palomino, R. A., "Extracellular vesicles from symbiotic vaginal lactobacilli inhibit HIV-1 infection of human tissues", Nat. Commun, 10, pp.5656~ (2019)
  46. Zocchi, L., "SIRT1-mediated deacetylation of MeCP2 contributes to BDNF expression", Epigenetics, 7, pp.695~700 (2012)
  47. Yan, D., "Effects of aluminium on long-term memory in rats and on SIRT1mediating the transcription of CREB-dependent gene in hippocampus", Basic Clin. Pharmacol. Toxicol, 121, pp.342~352 (2017)
  48. Bramham, C. R., "BDNF function in adult synaptic plasticity : the synaptic consolidation hypothesis", Prog. Neurobiol, 76, pp.99~125 (2005)
  49. Ghiglieri, V., "TrkB", BDNF-dependent striatal plasticity and behavior in a genetic model of epilepsy : modulation by Valproic Acid, 2010, pp.35, 1531~1540
  50. Sakata, K., "Role of activity-dependent BDNF expression in hippocampal–prefrontal cortical regulation of behavioral perseverance", Proc. Natl. Acad. Sci. USA, 110, pp.15103~15108 (2013)
  51. Bathina, S., "Brain-derived neurotrophic factor and its clinical implications", Arch. Med. Sci, 11, pp.1164~1178 (2015)
  52. Nagahara, A. H., "Early BDNF treatment ameliorates cell loss in the entorhinal cortex of APP transgenic mice", J. Neurosci, 33, pp.15596~15602 (2013)
  53. Wang, Z. H., "Deficiency in BDNF", TrkB neurotrophic activity stimulates δ-Secretase by upregulating C, Cell Rep, pp.2019, 28[DOI]
  54. Gao, L., "Brain‑derived neurotrophic factor in Alzheimer’s disease and its pharmaceutical potential", Transl. Neurodegener, 11, pp.4~ (2022)
  55. Juli Choi, "Hyperoxygenation Treatment Reduces Beta-amyloid Deposition via MeCP2-dependent Upregulation of MMP-2 and MMP-9 in the Hippocampus of Tg-APP", PS1 Mice, 2021, pp.30(4), 294~307[DOI]
  56. Shaftel, S. S., "Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology", J. Clin. Invest, 117, pp.1595~1604 (2007)
  57. Lee, D. C., "Review : experimental manipulations of microglia in mouse models of Alzheimer’s pathology : activation reduces amyloid but hastens tau pathology", Neuropathol. Appl. Neurobiol, 39, pp.69~85 (2013)
  58. Kiyota, T., "AAV serotype 2", 1-mediated gene delivery of anti-inflammatory interleukin-10 enhances neurogenesis and cognitive function in APP+PS1 mice, 2012, pp.19, 724~733
  59. Passamonti, L., "Neuroinflammation and functional connectivity in Alzheimer’s disease : interactive influences on cognitive performance", J. Neurosci, 39, pp.7218~7226 (2019)
  60. Bradburn, S., "Neuroinflammation in mild cognitive impairment and Alzheimer’s disease : a meta-analysis", Ageing Res. Rev, 50, pp.1~8 (2019)

관련 논문AI추천

Lactobacillus paracasei-derived extracellular vesicles reverse molecular and behavioral deficits in mouse models of autism spectrum disorderHan Pyung-Lim, Kim Ji-Eun, Kim Tae-Kyung, Kim Yoon-Keun, Lee Eun-Hwa, Paeng Jae-Won, Paeng Jin-Chul, Park Jin-Young생화학분자생물학회 · Experimental and Molecular Medicine2025 · 제57권 Heat-Killed Leuconostoc mesenteroides H40 Alleviates Cognitive Impairment by Anti-Inflammation and Antioxidant Effects in a Scopolamine-Induced Mouse Model이나경, Hwang Jiyoung, Lee Yunjung, Paik Hyun-Dong, Park Eunju한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2025 · 제35권 Protective Effects of Heat-Killed Ruminococcus albus against β-Amyloid-Induced Apoptosis on SH-SY5Y CellsAn Mirae, Choo Seungmoon, Lim Young-Hee한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2024 · 제34권 제1호Current understanding of the Alzheimer’s disease-associated microbiome and therapeutic strategiesHoltzman David M., Seo Dong-oh생화학분자생물학회 · Experimental and Molecular Medicine2024 · 제56권 Protective Effects of Bacillus coagulans JA845 against D-Galactose/AlCl3-Induced Cognitive Decline, Oxidative Stress and NeuroinflammationJin Qing, Li Shengyu, Song Xinping, Zhao Yujuan, Zhao Zijian한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2022 · 제32권 제2호Quantitative Sequencing Analysis of the Striatal Transcriptome in a Mouse Model of Alzheimer Disease김태규, 이상준, 임혜인대한배뇨장애요실금학회 · International Neurourology Journal2022 · 제26권 제1호

이 간행물의 다른 논문 (225건)